U.S. Trade Distributors Stock News

NYSE:PMT
NYSE:PMTMortgage REITs

Is PennyMac Mortgage Investment Trust (PMT) Using Preferred Dividends to Reframe Its Credit-Risk Strategy?

PennyMac Mortgage Investment Trust previously announced that its Board of Trustees declared first-quarter 2026 cash dividends on its 8.125% Series A (US$0.507813), 8.000% Series B (US$0.500000), and 6.750% Series C (US$0.421875) preferred shares, for shareholders of record on March 1, 2026, payable on March 16, 2026. Alongside confirming these preferred dividends and the tax treatment of 2025 payouts, the trust is shifting its portfolio toward more credit-sensitive mortgage assets and...
NYSE:AAT
NYSE:AATREITs

Is Lower 2025 Earnings and a Steady Dividend Altering The Investment Case For American Assets Trust (AAT)?

In early February 2026, American Assets Trust, Inc. reported past fourth quarter and full-year 2025 results, with revenue of US$110.09 million and net income of US$3.15 million for the quarter, and full-year revenue of US$436.20 million and net income of US$55.65 million, alongside a declared first-quarter 2026 dividend of US$0.340 per share. The earnings release highlighted lower year-on-year quarterly and annual revenue and earnings per share, yet the board maintained its cash dividend,...
NYSE:EXPD
NYSE:EXPDLogistics

Can Expeditors (EXPD) Turn Fee-Based Strength Into a Durable Edge in a Weak Freight Market?

Earlier in November 2025, Expeditors International of Washington reported quarterly earnings and revenue that exceeded Wall Street expectations despite a weak freight market. The results highlighted growth in airfreight tonnage and strong customs brokerage and fee-based services performance, even as analysts maintained a cautious Hold consensus. Next, we’ll examine how this resilient fee-based performance shapes Expeditors International’s broader investment narrative over the past...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

10x Genomics (TXG) Is Down 5.4% After Shelf Offer Filing And Cautious 2026 Outlook What's Changed

In February 2026, 10x Genomics reported fourth-quarter 2025 revenue of US$166.03 million with a reduced net loss of US$16.25 million, and filed a US$138.83 million shelf registration for 7,661,479 Class A shares tied to an employee stock plan. Alongside improved full-year 2025 loss metrics and cautious 2026 revenue guidance, 10x Genomics deepened its role in AI-driven cancer research through the PharosAI collaboration using its Xenium spatial platform. Next, we’ll assess how stronger cost...
NYSE:CDE
NYSE:CDEMetals and Mining

A Look At Coeur Mining (CDE) Valuation After Bullish Analyst Updates And New Gold Acquisition

Coeur Mining (CDE) is back in focus after a wave of bullish analyst updates related to its New Gold acquisition, expectations for strong near term free cash flow, and supportive gold and silver prices. See our latest analysis for Coeur Mining. At a share price of US$22.42, Coeur Mining has seen a 52.52% 90 day share price return and a very large 1 year total shareholder return of 248.68%, with multi year total shareholder returns also very strong. This suggests momentum has been building as...
NYSE:CRBG
NYSE:CRBGDiversified Financial

What Corebridge Financial (CRBG)'s 2025 Net Loss and Bigger Buybacks Mean For Shareholders

Corebridge Financial reported past fourth-quarter 2025 revenue of US$6,767 million, up from US$6,600 million a year earlier, but net income fell to US$814 million from US$2,171 million, with the full year swinging to a US$366 million net loss and a basic loss per share of US$0.68 from prior earnings. Alongside these mixed results, Corebridge continued to return capital through a higher quarterly dividend of US$0.25 per share and completion of roughly US$4.40 billions in buybacks, while also...
NYSE:SIG
NYSE:SIGSpecialty Retail

How Investors May Respond To Signet Jewelers (SIG) Valentine’s Day Boost In Holiday-Driven Sales Expectations

Recently, Signet Jewelers was highlighted for strong seasonal momentum as Valentine’s Day spending lifted expectations for higher sales during this key jewelry shopping period. This short-term boost in demand underscores how dependent the retailer’s performance can be on holiday-driven purchasing patterns and consumer sentiment. We’ll now examine how this holiday-driven optimism around Valentine’s Day spending aligns with or challenges the existing investment narrative for Signet. Invest in...
NYSE:OKE
NYSE:OKEOil and Gas

Is ONEOK (OKE) Pricing Reflecting Its Midstream Role And Recent Share Performance?

If you are wondering whether ONEOK’s current share price fairly reflects its underlying value, you are not alone. This article is built to help you connect the recent price action with the fundamentals. ONEOK closed at US$86.11, with returns of 3.2% over the past week, 15.7% over the last 30 days, 15.8% year to date and a 7.8% decline over the past year, alongside longer term returns of 52.4% over 3 years and 150.4% over 5 years. Recent news coverage around ONEOK has focused on its role as a...
NYSE:AAP
NYSE:AAPSpecialty Retail

Does Advance Auto Parts’ Profit Rebound and 2026 Outlook Change The Bull Case For AAP?

Advance Auto Parts recently reported fourth-quarter 2025 results showing US$1,973 million in sales and a return to profitability with US$6 million in net income, alongside improved margins and positive comparable sales growth. The company paired this earnings recovery with 2026 guidance for US$8,485 million to US$8,575 million in net sales and affirmed a regular US$0.25 per-share dividend, underscoring its ongoing turnaround and capital-return plans. We’ll now examine how this earnings...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Is It Too Early To Reconsider SoFi Technologies (SOFI) After Its Recent Share Price Slide?

If you are wondering whether SoFi Technologies at around US$19.61 is a bargain or already pricing in a lot of optimism, you are not alone. The stock has had a mixed run, with a 7.4% decline over the past week, a 25.0% decline over the past month, and a 28.6% decline year to date, while still showing a 16.5% return over the past year and a very large 3 year gain alongside a 2.5% decline over 5 years. These swings have kept SoFi on many watchlists, as investors reassess what they are willing...
NYSE:NLY
NYSE:NLYMortgage REITs

Annaly Declares Q1 2026 Preferred Dividends And Signals Income Priorities

Annaly Capital Management (NYSE:NLY) has declared quarterly preferred stock dividends for Q1 2026. The announcement covers multiple preferred series, with payments scheduled according to each series' terms. The decision directly affects preferred shareholders who rely on regular income distributions. Annaly Capital Management is a large mortgage real estate investment trust focused on owning and financing mortgage assets. For income focused investors, preferred shares of mortgage REITs sit...
NYSE:BK
NYSE:BKCapital Markets

Is BNY’s Latest ADR Mandate Deepening Its Role in Global Capital Flows (BK)?

In early February 2026, Chilwa Minerals Limited announced it had appointed Bank of New York Mellon as depositary bank for a sponsored ADR program, a key step as Chilwa advances toward a planned Nasdaq listing and seeks broader access to U.S. capital markets. This move reinforces BNY’s role at the center of cross-border capital flows by using its ADR infrastructure to connect overseas issuers with U.S. investors. We’ll now examine how BNY’s expanding ADR role for issuers like Chilwa Minerals...
NYSE:FLR
NYSE:FLRConstruction

Is Fluor (FLR) Offering Value After Recent 5% Pullback And Mixed Valuation Signals?

If you are wondering whether Fluor's current share price gives you good value, this article walks through what the numbers say about the stock and how to interpret them. Fluor recently closed at US$45.48, with returns of 3.4% over the last 30 days, 9.1% year to date and 14.4% over the past year, while the last 7 days saw a 5.5% decline. Recent news around Fluor has focused on its role as a major engineering and construction group and how investors view its project pipeline and sector...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Did Anito-cel’s D-Domain Safety Signal at Tandem Just Shift Arcellx's (ACLX) Investment Narrative?

Arcellx announced that a late-breaking abstract on its BCMA-directed CAR T therapy anitocabtagene autoleucel (anito-cel), featuring its novel D-Domain binder, was accepted and presented at the 2026 Tandem Meetings, highlighting preclinical data in relapsed or refractory multiple myeloma. The preclinical poster suggested that the compact D-Domain binder avoided tonic signaling and off-target activity seen with some other BCMA CAR constructs, potentially pointing to a differentiated safety...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Is Nutanix (NTNX) Priced Attractive After Recent Share Price Weakness

If you are wondering whether Nutanix at around US$41.76 is a bargain or a value trap, you are not alone. This article is here to walk you through what the current price might be telling you. The stock has had a mixed run, with a 0.3% decline over the last week, an 8.7% decline over the past month, a 17.5% decline year to date, but returns of 50.1% over 3 years and 30.6% over 5 years that may still catch the eye of longer term investors. Recent coverage has focused on Nutanix as a key player...
NYSE:IVZ
NYSE:IVZCapital Markets

How Investors Are Reacting To Invesco (IVZ) Beating Expectations With Income Appeal And ETF Focus

In recent weeks, Invesco reported revenue growth of 8.8% year on year, surpassing analyst expectations on revenue, EBITDA, and EPS while continuing to emphasize ETFs, digital initiatives, and private markets as key business areas. At the same time, Invesco has drawn attention with a dividend yield above its industry average, a history of dividend increases, and internal commentary highlighting opportunities in discounted UK equities and sector-focused ETFs. We’ll now examine how Invesco’s...
NYSE:NCLH
NYSE:NCLHHospitality

Is It Time To Reassess Norwegian Cruise Line Holdings (NCLH) After Prolonged Share Price Weakness

If you are wondering whether Norwegian Cruise Line Holdings is priced attractively right now, this article walks through what the current share price might imply about its value. The stock closed at US$21.49 recently, with a 7 day return of an 8.8% decline, a 30 day return of a 2.4% decline, a year to date return of a 5.7% decline and a 1 year return of a 21% decline, compared with a 3 year return of 26.6% and a 5 year return of a 24.9% decline. Recent headlines around Norwegian Cruise Line...
NYSE:GE
NYSE:GEAerospace & Defense

Has General Electric (GE) Run Too Far After Its 51% One Year Rally

If you are wondering whether General Electric's share price still makes sense after a strong run, this article is here to help you unpack what that price might be implying about value today. GE closed at US$315.41, with returns of 51.0% over 1 year and a very large gain over 3 years, while the last 7 days, 30 days and year to date show modest pullbacks of 0.3%, 3.0% and 1.7% respectively. Recent news around General Electric has mainly focused on its ongoing position in the capital goods...
NYSE:IOT
NYSE:IOTSoftware

Assessing Samsara (IOT) Valuation After Samsara Coach Super Bowl Launch

Samsara (IOT) is back in the spotlight after unveiling Samsara Coach, an AI-powered driver coaching tool introduced through a Super Bowl LX commercial featuring NASCAR champion Jesse Love as a digital avatar. See our latest analysis for Samsara. Despite the Super Bowl spotlight and recent expansion in Canada, momentum in Samsara’s share price has cooled, with a 30 day share price return of a 21.7% decline and a 1 year total shareholder return of a 55.2% decline, while the 3 year total...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

Assessing VEON (NasdaqGS:VEON) Valuation After Launch Of The Global Connect With Nutshell Group

VEON (VEON) has put fresh attention on its stock after partnering with Nutshell Group to launch The Global Connect, a new platform aimed at cross border investment and digital transformation in emerging economies. See our latest analysis for VEON. Recent news around The Global Connect comes after a period of softer momentum, with VEON’s 7 day and 30 day share price returns of 3.03% and 3.76% declines, while its 1 year total shareholder return of 15.02% and very large 3 year total shareholder...
NYSE:THR
NYSE:THRElectrical

Does Thermon (THR) Prioritize Deals Over Buybacks as Liquidity Rises and Repurchases Pause?

In early February 2026, Thermon Group Holdings reported third-quarter and nine-month results showing higher sales and slightly improved earnings per share year on year, while highlighting US$141 million in total cash and available liquidity to support growth initiatives. An interesting wrinkle is that Thermon completed a US$36.19 million share repurchase program by March 2024 yet bought back no shares in the most recent quarter, suggesting current capital is being preserved for potential...
NYSE:BHE
NYSE:BHEElectronic

What Benchmark Electronics (BHE)'s Q4 Profit Slide and Q1 2026 Outlook Means For Shareholders

Benchmark Electronics, Inc. recently reported its fourth-quarter 2025 results, with sales of US$704.33 million and diluted earnings per share from continuing operations of US$0.17, and issued first-quarter 2026 guidance calling for revenue between US$655 million and US$695 million and diluted GAAP EPS of US$0.31 to US$0.37. The combination of higher quarterly sales alongside a sharp year-on-year drop in net income to US$5.97 million gives investors a mixed picture of operational progress and...
NYSE:GRBK
NYSE:GRBKConsumer Durables

Assessing Green Brick Partners (GRBK) Valuation After Renewed Attention And Awards For Its Communities

Green Brick Partners (GRBK) is back on investors’ radar after fresh coverage linked the homebuilder to a high-conviction position in David Einhorn’s portfolio and highlighted new awards for its master-planned communities in North Texas. See our latest analysis for Green Brick Partners. The latest recognition for its communities comes alongside strong price momentum, with a 30.03% 3 month share price return and a 34.09% 1 year total shareholder return suggesting sentiment has strengthened over...
NasdaqGM:TNGX
NasdaqGM:TNGXBiotechs

Pivotal Vopimetostat Pancreatic Cancer Trial Plan Might Change The Case For Investing In Tango Therapeutics (TNGX)

Tango Therapeutics, Inc. recently presented at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 in New York, where President and CEO Malte Peters outlined plans to advance vopimetostat into a pivotal 300-patient randomized trial in second-line pancreatic cancer following supportive FDA interactions. The company also highlighted preclinical synergy between vopimetostat and Revolution Medicines’ RAS inhibitors, alongside early progress for CNS agent TNG456, signaling a broader...